While it did not affect the primary endpoint of major adverse cardiovascular events, targeted vitamin D supplementation was linked to reduced risk for recurrent heart attack, according to results of ...
Medpage Today on MSN
Salmonella Paratyphi A Vaccine Protected Against Infection
An investigational live attenuated vaccine led to protection against Salmonella enterica serovar Paratyphi A infection, ...
Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...
Single-fraction SBRT did not significantly improve bone pain compared to conventional RT. Complete response rates were 37% with SBRT versus 25% with 3D conformal RT at 1 month and remained ...
PARIS, France—A new analysis of more than 10,000 patients likely slams the door on routinely using cerebral embolic protection for stroke prevention in patients with aortic stenosis undergoing TAVI.
For decades, poor treatment options and low-quality evidence plagued care for patients with rifampin-resistant tuberculosis. The advent of new drugs to treat tuberculosis and enhanced funding now ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback